Open AccessAn Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy
Author(s) -
Aino Fianu Jonasson,
Mikael Åström
Publication year - 2021
Publication title -
medical devices
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.482
H-Index - 30
ISSN - 1179-1470
DOI - 10.2147/mder.s303234
Subject(s) - medicine , aromatase inhibitor , breast cancer , vaginal atrophy , adverse effect , adjuvant , adjuvant therapy , vagina , discontinuation , surgery , tamoxifen , cancer , gynecology , atrophy